<DOC>
	<DOC>NCT02687776</DOC>
	<brief_summary>Observational cohort study examining the perioperative course of copeptin in patients undergoing elevated-risk surgery.</brief_summary>
	<brief_title>Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery</brief_title>
	<detailed_description />
	<criteria>Adults &gt;18 years Type of surgery for patients 1 to 30: abdominal aortic aneurysm repair, suprainguinal and infrainguinal vascular surgery, carotid surgery Type of surgery for patients 31 to 500: surgeries with elevated risks in general (as specified by 2014 ESC/ESA Guidelines on noncardiac surgery: cardiovascular assessment and management [Kristensen]) acute coronary Syndrome (ACS) at presentation (clinical assessment or documentation) Congestive heart failure at presentation (clinical assessment or documentation) Documented severe aortic stenosis (valve area &lt;1cm2) Kidney dysfunction (clearance &lt;50ml/min) Reduced left ventricular ejection fraction (LVEF) (&lt;40%); if no LVEF is available, it will be assumed to be &gt;40% Cancelled surgery Unwilling or unable to provide consent Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Copeptin, human</keyword>
</DOC>